Target intelligence / Profile preview

N-methyl-D-aspartate receptor and voltage-gated sodium channels (NMDAR + VGSC)

Target
NMDAR + VGSC
Molecular classification
Ion channel, Receptor
01

Overview

The N-methyl-D-aspartate (NMDA) receptor and voltage-gated sodium channels (VGSCs) are distinct classes of ion channels that play fundamental roles in neuronal excitability and synaptic transmission. The NMDA receptor is a glutamate-gated cation channel that mediates the slow component of excitatory synaptic transmission and is crucial for long-term potentiation and memory formation [1: https://www.ncbi.nlm.nih.gov/books/NBK526134/]. Voltage-gated sodium channels are responsible for the rapid upstroke of the action potential, allowing for the propagation of electrical signals along axons [2: https://www.ncbi.nlm.nih.gov/books/NBK540972/]. In various pathological states, such as epilepsy, stroke, and chronic pain, overactivation of these channels leads to neuronal hyperexcitability and excitotoxicity [3: https://pubmed.ncbi.nlm.nih.gov/11511381/]. Pharmacological agents that target both NMDA receptors and VGSCs, such as lamotrigine and riluzole, are used to stabilize neuronal membranes and prevent excessive glutamate release or post-synaptic activation [4: https://pubchem.ncbi.nlm.nih.gov/compound/Lamotrigine, 5: https://pubmed.ncbi.nlm.nih.gov/11511381/]. This dual mechanism is particularly effective in treating refractory seizures and providing neuroprotection, although it requires careful management of side effects like dizziness and cognitive slowing [6: https://pubmed.ncbi.nlm.nih.gov/24552133/].

Other names
Glutamate [NMDA] receptor and NaV channelsNMDAR and voltage-dependent sodium channels
02

Mechanism of action

Dual inhibition of excitatory neurotransmission via NMDA receptor antagonism and stabilization of neuronal membranes through voltage-gated sodium channel blockade.

03

Biological functions

Synaptic plasticityAction potential propagationNeurotransmissionNeuronal excitability
04

Disease associations

EpilepsyNeuropathic painNeurodegenerative diseaseStrokeBipolar disorder
05

Safety considerations

Dissociative effectsCognitive impairmentAtaxiaDizzinessCardiac conduction delays
06

Interacting drugs

Lamotrigine

6 more in the full profile.

07

Biomarkers

Electroencephalogram (EEG) patternsCerebrospinal fluid (CSF) glutamate levelsQuantitative sensory testing (QST)

Beyond the preview

Go deeper on N-methyl-D-aspartate receptor and voltage-gated sodium channels (NMDAR + VGSC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-methyl-D-aspartate receptor and voltage-gated sodium channels (NMDAR + VGSC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call